| Description |
1 online resource : text file, PDF |
| Contents |
Cover; Half Title; Title Page; Copyright Page; Preface; Contents; Contributors; 1 Human Immunodeficiency Virus Prevention: Applying the Lessons Learned; I. INTERVENTION STRATEGIES: LEVELS OF INTERVENTION; A. Individual and Small-Group Counseling Interventions; B. Couples Interventions; C. Institutional-Level Interventions; D. Community-Level Interventions; E. Policy/Legal-Level Interventions; II. WHERE ARE THE NEEDS?; A. Men Who Have Sex with Men (MSM); B. Inner-City Women at High Risk for HIV Infection; C. Young Women in Their Teens |
|
D. Populations Whose Risk Behaviors Are Influenced by AlcoholE. HIV-Infected Persons; III. WHAT CAN WE RECOMMEND NOW?; IV. CONCLUSION; REFERENCES; 2 Novel Strategies Toward the Development of an Effective Vaccine to Prevent Human Immunodeficiency Virus Infection or Acquired Immunodeficiency Virus; I. HOW AIDS VACCINE STRATEGIES HAVE EVOLVED FROM STERILIZING IMMUNITY TO THE CONTROL OF INFECTION; II. LIVE ATTENUATED VACCINES: CONCEPTS TO LEARN; III. NOVEL STRATEGIES; A. Fusion-Competent Env-Based Vaccine |
|
B. Vaccines Based on Naked DNA and Live Vectors Expressing Env Alone or Associated with Other Viral Genes (MVA, Canarypox, Fowlpox, Adenovirus, Alphavi ruses)C. Polyepitope Vaccines; D. Vaccine Based on Regulatory Genes: Tat, Rev, Nef; E. Alloimmunization for Anti-HIV Vaccine; IV. CONCLUSIONS AND PERSPECTIVES; Acknowledgments; REFERENCES; 3 Pediatrie Human Immunodeficiency Virus Type 1 Infection: Updates on Prevention and Management; I. INTRODUCTION; II. MATERNAL AND OBSTETRICAL FACTORS ASSOCIATED WITH PERINATAL HIV-1 TRANSMISSION; A. Breastfeeding; B. Exposure to Maternal Blood and Virus |
|
C. Antiretroviral Prophylaxis of the InfantD. Obstetrical Management; III. ANTIRETROVIRAL THERAPY FOR HIV-1-INFECTED CHILDREN; IV. SUMMARY; REFERENCES; 4 Risk of Human Immunodeficiency Virus Infection in Health Care Workers; I. INTRODUCTION; II. ANECDOTAL CASE REPORTS OF OCCUPATIONAL HIV INFECTION; III. PROSPECTIVE COHORT STUDIES; IV. PREVENTION; V. MANAGEMENT OF OCCUPATIONAL EXPOSURE; VI. HIV-INFECTED HEALTH CARE WORKERS: RISKS TO PATIENTS; VII. CONCLUSION; REFERENCES; 5 Can Immune Responses to Human Immunodeficiency Virus Be Preserved, Enhanced, or Restored?; I. INTRODUCTION |
|
II. COMPONENTS OF PROTECTIVE IMMUNITY IN HIV INFECTIONIII. WHY DOES THE IMMUNE SYSTEM FAIL TO CONTROL HIV?; IV. EFFECTS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) ON HIV-SPECIFIC IMMUNE RESPONSES; V. REBUILDING THE IMMUNE SYSTEM IN CHRONIC HIV INFECTION; VI. CRITICAL NEED FOR IMMUNOTHERAPY PLUS HAART IN AUGMENTING IMMUNITY TO HIV; VII. APPROACHES TO IMMUNE ENHANCEMENT IN HIV INFECTION; VIII. CONCLUSIONS AND FUTURE DIRECTIONS; REFERENCES; 6 Reconstitution of Immunity Against Opportunistic Infections in the Era of Potent Antiretroviral Therapy; I. INTRODUCTION; II. PCP; III. MAC; IV. CMV |
| Summary |
"The latest in the crucial series documenting scientific discoveries at the forefront of HIV and AIDS research!This volume updates the most important and controversial issues facing physicians, nurses, microbiologists, pharmacists, and epidemiologists who deal directly with patients suffering from HIV and AIDS, focusing on specific areas in which important new advances have occurred in diagnosis, therapy, and prevention of infection and related complications. Outlines new disease management strategies being tested in prospective clinical trials and observational studies!Combining elements of virology, epidemiology, immunology, oncology, endocrinology, neurology, psychiatry, and the behavioral sciences, AIDS Clinical Review 2000/2001clarifies substantive advancements in vaccine development, realistically assessing potential efficacy and limitations explores short-term antiretroviral therapy for dramatically reducing the rate of vertical transmission from mother to child evaluates the efficacy of antiretroviral prophylaxis for workers who experience high-risk exposure to HIV-infected blood discusses preservation of HIV specific immunity when antiretroviral therapy is initiated early in the course of acute infection considers complex drug interactions that occur when drugs are used in combination highlights cytokine and other immune-based therapies suggests chronic hepatitis may ultimately be more fatal than HIV for coinfected patients and more!Including results recently presented at scientific meetings but not yet published in peer-reviewed journals, AIDS Clinical Review 2000/2001 is essential reading for infectious disease specialists, epidemiologists, virologists, immunologists, pharmacologists, microbiologists, hematologists, hepatologists, oncologists, neurologists, medical students in these disciplines, and all medical professionals involved in both AIDS research and clinical practice."--Provided by publisher |
| Bibliography |
Includes bibliographical references and index |
| Subject |
Communicable diseases
|
|
Infection.
|
|
Hematology.
|
|
Communicable Diseases
|
|
Infections
|
|
Hematology
|
|
Communicable diseases
|
|
Hematology
|
|
Infection
|
| Form |
Electronic book
|
| Author |
Volberding, Paul A., editor
|
| ISBN |
9781420002652 |
|
1420002651 |
|
